Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Albireo Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Albireo Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Chiswell David | Director | 0 | Mar 3, 2023 | 0 |
| Carter Martha J. | Chief Regulatory Officer | 3,654 | Mar 2, 2023 | 0 |
| Scoon Davey | Director | – | Mar 2, 2023 | 0 |
| Harford Simon N.R. | CFO and Treasurer | 0 | Mar 2, 2023 | 0 |
| Graham Michelle | Chief Human Resources Officer | 0 | Mar 2, 2023 | 0 |
| Cooper Ronald Harold Wilfred | President and CEO | 0 | Mar 2, 2023 | 0 |
| Gutch Michael | Director | – | Mar 2, 2023 | 0 |
| Mattsson Jan | Chief Scientific Officer | 0 | Mar 2, 2023 | 0 |
| Dable Habib J | Director | – | Mar 2, 2023 | 0 |
| Streck Paul | Chief Medical Officer | 118,966 | Mar 2, 2023 | 0 |
| Hopkinson Craig C. | Director | 10,495 | Mar 2, 2023 | 0 |
| Duncan Jason | Chief Legal Officer and GC | 0 | Mar 2, 2023 | 0 |
| Okey Stephanie | Director | – | Mar 2, 2023 | 0 |
| Stephenson Pamela | Chief Commercial Officer | 0 | Mar 2, 2023 | 0 |
| Alesina Susan | Director | – | Mar 2, 2023 | 0 |
| Edelman Joseph | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Perceptive Advisors LLC | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 1,939,723Indirect | Oct 13, 2022 | 0 |
| Horn Patrick Taylor | Chief Medical Officer | 12,355 | Oct 25, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 (view filing) | Jan 19 | 1 day | Stephenson PamelaChief Commercial Officer | SSale | −1.77K | $43.90 | −$77.9K | −4.0%42.9K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Carter Martha J.Chief Regulatory Officer | SSale | −120 | $43.80 | −$5.26K | −0.8%14.5K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Cooper Ronald Harold WilfredPresident and CEO | SSale | −1.06K | $43.80 | −$46.3K | −1.8%57.4K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Duncan JasonChief Legal Officer and GC | SSale | −228 | $43.80 | −$9.99K | −1.6%14.1K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Harford Simon N.R.CFO and Treasurer | SSale | −102 | $43.80 | −$4.47K | −0.3%32.7K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Mattsson JanChief Scientific Officer | SSale | −197 | $43.80 | −$8.63K | −0.4%54.5K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Graham MichelleChief Human Resources Officer | SSale | −102 | $43.80 | −$4.47K | −0.4%24.5K after | |
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Stephenson PamelaChief Commercial Officer | SSale | −102 | $43.80 | −$4.47K | −0.2%42.8K after |